These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3400656)

  • 21. Compatibility of various admixtures with secondary additives at Y-injection sites of intravenous administration sets.
    Allen LV; Levinson RS; Phisutsinthop D
    Am J Hosp Pharm; 1977 Sep; 34(9):939-43. PubMed ID: 20779
    [No Abstract]   [Full Text] [Related]  

  • 22. The compatibility of nicardipine hydrochloride injection with various ICU medications during simulated Y-site injection.
    Halpern NA; Colucci RD; Alicea M; Greenstein R
    Int J Clin Pharmacol Ther Toxicol; 1989 May; 27(5):250-4. PubMed ID: 2737791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Visual compatibility of amiodarone hydrochloride injection with various intravenous drugs.
    Chalmers JR; Bobek MB; Militello MA
    Am J Health Syst Pharm; 2001 Mar; 58(6):504-6. PubMed ID: 11286148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Visual compatibility of midazolam hydrochloride with selected drugs during simulated Y-site injection.
    Mantong ML; Marquardt ED
    Am J Health Syst Pharm; 1995 Nov; 52(22):2567-8. PubMed ID: 8590242
    [No Abstract]   [Full Text] [Related]  

  • 25. Compatibility of aminophylline and verapamil in intravenous admixtures.
    Johnson CE; Lloyd CW; Mesaros JL; Rubley GJ
    Am J Hosp Pharm; 1989 Jan; 46(1):97-100. PubMed ID: 2712035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Compatibility of granisetron hydrochloride with selected alkaline drugs.
    Trissel LA; Martinez JF
    Am J Health Syst Pharm; 1995 Jan; 52(2):208. PubMed ID: 12879553
    [No Abstract]   [Full Text] [Related]  

  • 27. Visual compatibility of ciprofloxacin with selected components of total parenteral nutrient solutions during simulated Y-site injection.
    Percy LA; Rho JP
    Am J Hosp Pharm; 1993 Apr; 50(4):715-6. PubMed ID: 8470693
    [No Abstract]   [Full Text] [Related]  

  • 28. Visual compatibility of zidovudine with other injectable drugs during simulated Y-site administration.
    Bashaw ED; Amantea MA; Minor JR; Gallelli JF
    Am J Hosp Pharm; 1988 Dec; 45(12):2532-3. PubMed ID: 3228107
    [No Abstract]   [Full Text] [Related]  

  • 29. Visual compatibility of doxapram hydrochloride with drugs commonly administered via a Y-site in the intensive care nursery.
    Bell MS; Nolt DH
    Am J Health Syst Pharm; 2003 Jan; 60(2):193-4. PubMed ID: 12561666
    [No Abstract]   [Full Text] [Related]  

  • 30. Visual compatibility of intravenous famotidine with selected drugs.
    Fong PA; Ward J
    Am J Hosp Pharm; 1989 Jan; 46(1):125-6. PubMed ID: 2565686
    [No Abstract]   [Full Text] [Related]  

  • 31. Visual compatibility of enalaprilat with commonly used critical care medications during simulated Y-site injection.
    Halpern NA; Colucci RD; Alicea M; Greenstein R
    Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):294-7. PubMed ID: 2544533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visual compatibility of sodium nitroprusside with other injectable medications given to pediatric patients.
    Seto W; Trope A; Carfrae L; Walker S
    Am J Health Syst Pharm; 2001 Aug; 58(15):1422-6. PubMed ID: 11494788
    [No Abstract]   [Full Text] [Related]  

  • 33. Flow injection chemiluminescent determination of amiodarone in pharmaceutical preparations using photogenerated tris(2,2'-bipyridyl)ruthenium(III).
    Pérez-Ruiz T; Martínez-Lozano C; Martín J; Ruiz E
    J Pharm Biomed Anal; 2006 Sep; 42(1):143-7. PubMed ID: 16458471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Visual compatibility of cibenzoline succinate with commonly used acute-care medications.
    Dahl JM; Roche VF; Hilleman DE
    Am J Hosp Pharm; 1987 May; 44(5):1123-5. PubMed ID: 3605123
    [No Abstract]   [Full Text] [Related]  

  • 35. Compatibility of ondansetron hydrochloride with fluconazole, ceftazidime, aztreonam, and cefazolin sodium under simulated Y-site conditions.
    Bosso JA; Prince RA; Fox JL
    Am J Hosp Pharm; 1994 Feb; 51(3):389-91. PubMed ID: 8160696
    [No Abstract]   [Full Text] [Related]  

  • 36. Visual compatibility of ceftizoxime sodium in four electrolyte injections.
    Swenson E; Gooch WM; Higbee MD
    Am J Hosp Pharm; 1986 Sep; 43(9):2242-4. PubMed ID: 3766586
    [No Abstract]   [Full Text] [Related]  

  • 37. Visual compatibility of esmolol hydrochloride and various injectable drugs during simulated Y-site injection.
    Colucci RD; Cobuzzi LE; Halpern NA
    Am J Hosp Pharm; 1988 Mar; 45(3):630-2. PubMed ID: 2897164
    [No Abstract]   [Full Text] [Related]  

  • 38. Visual compatibility of narcotic analgesics with selected intravenous admixtures.
    Smythe MA; Patel MA; Gasloli RA
    Am J Hosp Pharm; 1990 Apr; 47(4):819-20. PubMed ID: 1969712
    [No Abstract]   [Full Text] [Related]  

  • 39. Visual compatibility of foscarnet with other injectable drugs during simulated Y-site administration.
    Baltz JK; Kennedy P; Minor JR; Gallelli J
    Am J Hosp Pharm; 1990 Sep; 47(9):2075-7. PubMed ID: 2145761
    [No Abstract]   [Full Text] [Related]  

  • 40. Compatibility of ciprofloxacin lactate with sodium bicarbonate during simulated Y-site administration.
    Gilbert DL; Trissel LA; Martinez JF
    Am J Health Syst Pharm; 1997 May; 54(10):1193-5. PubMed ID: 9161629
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.